Xvivo Perfusion AB (XVIPF)
21.80
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Xvivo Perfusion Profit Margin (Quarterly) : 6.81% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.81% |
| March 31, 2026 | 15.06% |
| December 31, 2025 | 14.00% |
| September 30, 2025 | 2.29% |
| June 30, 2025 | 0.88% |
| March 31, 2025 | -5.67% |
| December 31, 2024 | 15.99% |
| September 30, 2024 | 43.24% |
| June 30, 2024 | 12.93% |
| March 31, 2024 | 12.25% |
| December 31, 2023 | 43.97% |
| September 30, 2023 | 1.56% |
| June 30, 2023 | 4.45% |
| March 31, 2023 | 10.08% |
| December 31, 2022 | 0.56% |
| September 30, 2022 | 5.57% |
| June 30, 2022 | 7.99% |
| March 31, 2022 | 5.14% |
| December 31, 2021 | 14.20% |
| September 30, 2021 | -2.06% |
| June 30, 2021 | -15.09% |
| March 31, 2021 | 10.34% |
| December 31, 2020 | -32.48% |
| September 30, 2020 | -34.36% |
| June 30, 2020 | -52.70% |
| Date | Value |
|---|---|
| March 31, 2020 | 14.08% |
| December 31, 2019 | -3.05% |
| September 30, 2019 | 9.07% |
| June 30, 2019 | 3.95% |
| March 31, 2019 | -0.66% |
| December 31, 2018 | 8.37% |
| September 30, 2018 | 0.24% |
| June 30, 2018 | 8.45% |
| March 31, 2018 | 8.96% |
| December 31, 2017 | 13.39% |
| September 30, 2017 | -1.09% |
| June 30, 2017 | 2.94% |
| March 31, 2017 | -0.12% |
| December 31, 2016 | -1.51% |
| September 30, 2016 | -1.74% |
| June 30, 2016 | 4.41% |
| March 31, 2016 | 3.32% |
| December 31, 2015 | 8.56% |
| September 30, 2015 | 4.23% |
| June 30, 2015 | 4.40% |
| March 31, 2015 | -3.21% |
| December 31, 2014 | -1.22% |
| September 30, 2014 | 6.59% |
| June 30, 2014 | 4.07% |
| March 31, 2014 | 9.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Getinge AB | 10.01% |
| Paxman AB | 2.44% |
| Enovis Corp. | -0.18% |
| Edwards Lifesciences Corp | 13.87% |
| IDEXX Laboratories, Inc. | 27.82% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.23% |
| Return on Assets | 3.72% |
| Return on Invested Capital | 4.00% |
| Gross Profit Margin (Quarterly) | 63.23% |
| Operating Margin (Quarterly) | 9.22% |
| Return on Net Operating Assets | 4.62% |